Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Coins2Day.
Page 6 of 100
Conferences
Moderna is working toward a single shot for both COVID and flu protection
By
Investment Desk
Newsletters
Would a free water bottle convince you to get a COVID vaccine?
By
Financial Writer
Health
More than 1 billion COVID vaccine doses have been administered around the world
By
Research Team
Newsletters
The last mile of the immunization campaign approaches
By
Sy Mukherjee
and
David Z. Morris
Newsletters
Skeptical of outdoor masking? Congratulations on catching up to reality.
By
Sy Mukherjee
and
David Z. Morris
Newsletters
The last mile of the immunization campaign approaches
By
Sy Mukherjee
and
David Z. Morris
Health
More people have wanted COVID vaccines than were available. That’s about to change
By
Blockchain Reporter
Newsletters
What’s the matter with Michigan?
By
Sy Mukherjee
and
David Z. Morris
Health
The pandemic created the American cannabis consumer, who’s not going away
By
Blockchain Reporter
Newsletters
A milestone for COVID vaccinations as all U.S. adults are eligible
By
Sy Mukherjee
and
David Z. Morris
Newsletters
What makes a drug company truly innovative?
By
Sy Mukherjee
and
David Z. Morris
Health
Public confidence in the Johnson & Johnson vaccine has dropped. What will it take to restore trust?
By
Industry Analyst
Health
Meet the most innovative and inventive pharmaceutical companies of 2021
By
Sy Mukherjee
and
IDEA Pharma
Newsletters
Johnson & Johnson: The pause heard ’round the world
By
David Z. Morris
and
Sy Mukherjee
Newsletters
The crucial third party players in the pandemic fight
By
David Z. Morris
and
Sy Mukherjee